Ubiquitin‐specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation. Issue 2 (2nd May 2021)
- Record Type:
- Journal Article
- Title:
- Ubiquitin‐specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation. Issue 2 (2nd May 2021)
- Main Title:
- Ubiquitin‐specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation
- Authors:
- Xiao, Yue
Ma, Wenjing
Hu, Weiwei
Di, Qianqian
Zhao, Xibao
Ma, Xingyu
Chen, Xinyi
Sun, Ping
Wu, Han
Wu, Zherui
Chen, Weilin - Abstract:
- Abstract : Glioma cells are characterized by high migration and invasion ability; however, the molecular mechanism behind both processes still remains to be investigated. Several studies have demonstrated that ubiquitin‐specific protease 39 (USP39) plays an oncogenic role in various cancer types. Here, we investigated the expression and function of USP39 in patients with glioma. Oncomine database analysis revealed that high USP39 expression was significantly correlated with poor overall survival in patients with glioma. Knockdown of USP39 in U251 and U87 cell lines significantly inhibited their migration and invasion in vitro . Gene expression profiling of glioma cells transduced with short hairpin RNA (shRNA) against USP39 revealed that disintegrin and metalloproteinase domain‐containing protein 9 (ADAM9), a molecule previously related to tumor cell migration and invasion, was significantly downregulated. Furthermore, USP39 induced ADAM9 messenger RNA (mRNA) maturation and decreased the expression of integrin β1. Additionally, overexpression of ADAM9 inhibited the migration and invasion of glioma cells caused by USP39 depletion in vitro . USP39 promoted the invasion of glioma cells in vivo and reduced the overall survival of the mice. Altogether, our data show that USP39 induces mRNA maturation and elevates the expression of ADAM9 in glioma cells and may thus be considered potential target for treating patients with glioma. Abstract : Our study shows that ubiquitin‐specificAbstract : Glioma cells are characterized by high migration and invasion ability; however, the molecular mechanism behind both processes still remains to be investigated. Several studies have demonstrated that ubiquitin‐specific protease 39 (USP39) plays an oncogenic role in various cancer types. Here, we investigated the expression and function of USP39 in patients with glioma. Oncomine database analysis revealed that high USP39 expression was significantly correlated with poor overall survival in patients with glioma. Knockdown of USP39 in U251 and U87 cell lines significantly inhibited their migration and invasion in vitro . Gene expression profiling of glioma cells transduced with short hairpin RNA (shRNA) against USP39 revealed that disintegrin and metalloproteinase domain‐containing protein 9 (ADAM9), a molecule previously related to tumor cell migration and invasion, was significantly downregulated. Furthermore, USP39 induced ADAM9 messenger RNA (mRNA) maturation and decreased the expression of integrin β1. Additionally, overexpression of ADAM9 inhibited the migration and invasion of glioma cells caused by USP39 depletion in vitro . USP39 promoted the invasion of glioma cells in vivo and reduced the overall survival of the mice. Altogether, our data show that USP39 induces mRNA maturation and elevates the expression of ADAM9 in glioma cells and may thus be considered potential target for treating patients with glioma. Abstract : Our study shows that ubiquitin‐specific protease 39 (USP39) is highly expressed in human glioma and the high USP39 expression significantly correlated with poor overall survival in patients with glioma. USP39 promotes the migration and invasion of glioma cells in vitro and in vivo . Mechanically, USP39 induced disintegrin and metalloproteinase domain‐containing protein 9 mRNA maturation and decreased the expression of integrin β1. … (more)
- Is Part Of:
- Molecular oncology. Volume 16:Issue 2(2022)
- Journal:
- Molecular oncology
- Issue:
- Volume 16:Issue 2(2022)
- Issue Display:
- Volume 16, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 16
- Issue:
- 2
- Issue Sort Value:
- 2022-0016-0002-0000
- Page Start:
- 388
- Page End:
- 404
- Publication Date:
- 2021-05-02
- Subjects:
- ADAM9 -- glioma -- invasion -- migration -- messenger RNA maturation -- USP39
Cancer -- Molecular aspects -- Periodicals
616.994005 - Journal URLs:
- http://www.journals.elsevier.com/molecular-oncology/ ↗
http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/issues/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/1878-0261.12958 ↗
- Languages:
- English
- ISSNs:
- 1574-7891
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817993
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20386.xml